Skip to Main

Kevin D'souza is a member of Boston Consulting Group's Operations and Health Care practices. He leads BCG's work in quality and regulatory in pharmaceuticals and medtech globally. 

Since joining BCG in 2006, Kevin has focused on large-scale transformations. He has significant experience leading operational excellence programs including operating model restructurings and redesigns that are driven by M&A and divestitures. Kevin has also led BCG's manufacturing Strategy topic (including externalization and make versus buy) in North America.

During his BCG career, he has supported clients in the US and Canada, Europe (UK, Ireland, France, Germany, Switzerland) and Asia (India, Singapore, Bangladesh) on lean, plant optimization, quality, and other transformation topics.

AREAS OF EXPERTISE

EDUCATION

  • PGDM, Indian Institute of Management, Ahmedabad
  • BEng, Veermata Jijabai Technological Institute, Mumbai University

Publications and Videos

Complaint Management Is a Powerful Source of Value in Health Care | rectangle

Complaint Management Is a Powerful Source of Value in Health Care

Biopharma and medtech companies that adopt a digital-native approach can generate better outcomes, lower costs, and greater customer satisfaction.
medtech-manufacturing-2880x1620-tcm9-178869.jpg

Medtech Manufacturing’s Inflection Point

In the past, high medtech manufacturing margins made inefficient production tolerable. Today, companies must rethink their manufacturing strategy—with big rewards for getting it right.
raising-biopharma-mfg-quality-cvr-1694x950-tcm9-61020.jpg

Raising the Bar on Biopharma Manufacturing Quality

Biopharmaceutical manufacturing quality levels remain below those of other industries—making it critical for biopharma companies to up the effectiveness and efficiency of their quality efforts.